349 related articles for article (PubMed ID: 27556861)
21. [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
Iatsenko NM; Tsintsadze TSh; Lozova NO
Fiziol Zh (1994); 2007; 53(3):31-7. PubMed ID: 17725041
[TBL] [Abstract][Full Text] [Related]
22. Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord.
Milne M; Ashton JC
Neurosci Lett; 2016 Feb; 614():39-42. PubMed ID: 26762784
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Gustafsson K; Christensson B; Sander B; Flygare J
Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
28. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
29. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.
Patwardhan AM; Jeske NA; Price TJ; Gamper N; Akopian AN; Hargreaves KM
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11393-8. PubMed ID: 16849427
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons.
Tan R; Cao L
Int J Mol Med; 2018 Aug; 42(2):919-925. PubMed ID: 29786105
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
32. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
33. WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: involvement of p38 MAP kinase.
Sheng WS; Hu S; Ni HT; Rock RB; Peterson PK
J Neuroimmune Pharmacol; 2009 Jun; 4(2):244-8. PubMed ID: 19214751
[TBL] [Abstract][Full Text] [Related]
34. The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.
Fields JA; Swinton MK; Montilla-Perez P; Ricciardelli E; Telese F
Cannabis Cannabinoid Res; 2022 Feb; 7(1):78-92. PubMed ID: 33998879
[No Abstract] [Full Text] [Related]
35. Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells.
Ramer R; Weinzierl U; Schwind B; Brune K; Hinz B
Mol Pharmacol; 2003 Nov; 64(5):1189-98. PubMed ID: 14573769
[TBL] [Abstract][Full Text] [Related]
36. Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro.
Mbvundula EC; Bunning RA; Rainsford KD
J Pharm Pharmacol; 2006 Mar; 58(3):351-8. PubMed ID: 16536902
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
38. Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells.
Germain N; Boichot E; Advenier C; Berdyshev EV; Lagente V
Int Immunopharmacol; 2002 Mar; 2(4):537-43. PubMed ID: 11962732
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Cagni P; Barros M
Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
[TBL] [Abstract][Full Text] [Related]
40. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
